The 4th Targeted Radiopharmaceuticals Summit US returned to San Diego, uniting 275+ global stakeholders from biotech, pharma, and academia, to tackle these challenges head on. As the industry’s premier end-to-end platform, the summit was solely dedicated to accelerating the development and delivery of next-generation TRP therapeutics to capitalize on the potential of nuclear medicine. Across 3 days jam-packed with content across three focused tracks, we explored cutting-edge targeting molecules,
Tuesday, July 29, 2025 - Thursday, July 31, 2025
San Diego, USA
275 expected
The 4th Targeted Radiopharmaceuticals Summit US returned to San Diego, uniting 275+ global stakeholders from biotech, pharma, and academia, to tackle these challenges head on. As the industry’s premier end-to-end platform, the summit was solely dedicated to accelerating the development and delivery of next-generation TRP therapeutics to capitalize on the potential of nuclear medicine. Across 3 days jam-packed with content across three focused tracks, we explored cutting-edge targeting molecules,
Get curated B2B events, AI-powered insights, and industry trends delivered to your inbox